This story describes a medical research protocol that will determine whether patients with heart attacks and congestive heart failure can be helped with their own bone marrow stem cells. The difference between stem cell treatments and existing therapies is profound: “The potential new benefit from stem cell therapy is the ability to prevent [heart] muscle loss, whereas other options compensate for muscle loss.” In other words, if the stem cell therapy works, the patient will literally be better biologically, whereas the heart drugs for the condition currently in use seek to circumvent and overcome the dysfunction caused by underlying disease.
Moral Certitude and the Iran War
The current military engagement with Iran calls renewed attention to just war theory in the Catholic tradition.…
The Slow Death of England: New and Notable Books
The fate of England is much in the news as popular resistance to mass immigration grows, limits…
Ethics of Rhetoric in Times of War
What we say matters. And the way we say it matters. This is especially true in times…